Role of atherosclerosis assessment and other novel markers in the metabolic syndrome

Catherine Y. Campbell, Khurram Nasir, Nathan D. Wong, Roger S. Blumenthal

Research output: Contribution to journalReview articlepeer-review

Abstract

The metabolic syndrome is a constellation of cardiovascular disease risk factors predisposing to future cardiovascular disease events as well as the development of type 2 diabetes mellitus. This syndrome is closely linked to both subclinical atherosclerosis and vascular inflammation. The extent of vascular inflammation can be estimated by a number of biomarkers, such as high-sensitivity C-reactive protein, that are associated with the presence of the metabolic syndrome. Evaluating for the presence of subclinical atherosclerosis and inflammatory biomarkers may help to risk stratify patients with the metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)261-269
Number of pages9
JournalMetabolic Syndrome and Related Disorders
Volume4
Issue number4
DOIs
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Role of atherosclerosis assessment and other novel markers in the metabolic syndrome'. Together they form a unique fingerprint.

Cite this